WT1 and PAX-2 Podocyte Expression in Denys-Drash Syndrome and Isolated Diffuse Mesangial Sclerosis
- 1 January 1999
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 154 (1), 181-192
- https://doi.org/10.1016/s0002-9440(10)65264-9
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Identification of Constitutional WT1 Mutations, in Patients with Isolated Diffuse Mesangial Sclerosis, and Analysis of Genotype/Phenotype Correlations by Use of a Computerized Mutation DatabaseAmerican Journal of Human Genetics, 1998
- Expression of the Wilms' tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study.Molecular Pathology, 1997
- Identification of nuclear localization signals within the zinc fingers of the WT1 tumor suppressor gene productFEBS Letters, 1996
- DNA binding capacity of the WT1 protein is abolished by Denys—Drash syndrome WT1 point mutationsHuman Molecular Genetics, 1995
- Microcephaly and congenital nephrotic syndrome owing to diffuse mesangial sclerosis: an autosomal recessive syndrome.Journal of Medical Genetics, 1994
- WT-1 is required for early kidney developmentCell, 1993
- Evidence that WT1 mutations in Denys — Drash syndrome patients may act in a dominant-negative fashionHuman Molecular Genetics, 1993
- Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndromeCell, 1991
- FAMILIAL EARLY‐ONSET NEPHROTIC SYNDROME: DIFFUSE MESANGIAL SCLEROSISActa Paediatrica, 1982
- A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal diseaseThe Journal of Pediatrics, 1970